Simultaneous co-assembly of fenofibrate and ketoprofen peptide for the dual-targeted treatment of nonalcoholic fatty liver disease (NAFLD).

Wang, Zhongyan; Ma, Chuanrui; Shang, Yuna; Yang, Lijun; Zhang, Jing; Yang, Cuihong; Ren, Chunhua; Liu, Jinjian; Fan, Guanwei; Liu, Jianfeng

Wang, Zhongyan; Ma, Chuanrui; Shang, Yuna; Yang, Lijun; Zhang, Jing; Yang, Cuihong; Ren, Chunhua; Liu, Jinjian; Fan, Guanwei; Liu, Jianfeng.

Affiliation

Wang Z; Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, P. R. China. liujianfeng@irm-cams.ac.cn.

Chem Commun (Camb) ; 56(36): 4922-4925, 2020 May 04.

Article in En | MEDLINE | ID: mdl-32239031

Subject(s)

Fenofibrate/pharmacology; Inflammation/drug therapy; Ketoprofen/pharmacology; Non-alcoholic Fatty Liver Disease/drug therapy; Peptides/pharmacology; Fenofibrate/chemistry; Humans; Inflammation/metabolism; Ketoprofen/chemistry; Lipid Metabolism/drug effects; Molecular Structure; Non-alcoholic Fatty Liver Disease/metabolism; Peptides/chemical synthesis; Peptides/chemistry

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Fenofibrate / Ketoprofen / Non-alcoholic Fatty Liver Disease / Inflammation Limits: Humans Language: En Journal: Chem Commun (Camb) Journal subject: QUIMICA Year: 2020 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google